These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484 [TBL] [Abstract][Full Text] [Related]
6. Characterization of inhibitory action of concanamycins against herpes simplex virus. Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322 [TBL] [Abstract][Full Text] [Related]
7. Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Brezáni V; Leláková V; Hassan STS; Berchová-Bímová K; Nový P; Klouček P; Maršík P; Dall'Acqua S; Hošek J; Šmejkal K Viruses; 2018 Jul; 10(7):. PubMed ID: 29986399 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601 [TBL] [Abstract][Full Text] [Related]
9. The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus. Akanitapichat P; Bastow KF Antiviral Res; 2002 Feb; 53(2):113-26. PubMed ID: 11750937 [TBL] [Abstract][Full Text] [Related]
10. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus]. Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669 [TBL] [Abstract][Full Text] [Related]
11. Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress. Chen D; Su A; Fu Y; Wang X; Lv X; Xu W; Xu S; Wang H; Wu Z Antiviral Res; 2015 Nov; 123():27-38. PubMed ID: 26348003 [TBL] [Abstract][Full Text] [Related]
13. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives. Lowden CT; Bastow KF Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of the antiherpesvirus biflavone ginkgetin. Hayashi K; Hayashi T; Morita N Antimicrob Agents Chemother; 1992 Sep; 36(9):1890-3. PubMed ID: 1329635 [TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus latency after direct ganglion virus inoculation. Hay KA; Edris WA; Gaydos A; Tenser RB J Neurovirol; 1998 Oct; 4(5):531-8. PubMed ID: 9839650 [TBL] [Abstract][Full Text] [Related]
16. Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects. Lazdins J; Alteri E; Cook KW; Burgin C; Gangemi JD Antiviral Res; 1990 Apr; 13(4):175-86. PubMed ID: 2166467 [TBL] [Abstract][Full Text] [Related]
17. Methods for screening and profiling inhibitors of herpes simplex viruses. Gong EY Methods Mol Biol; 2013; 1030():303-13. PubMed ID: 23821277 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo. Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320 [TBL] [Abstract][Full Text] [Related]